“Long-term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-year Results from the ALLEGRO-LT Phase 3, Open-label Study”, J of Skin, vol. 9, no. 4, p. s582, Jul. 2025, doi: 10.25251/gdd40x24.